Models for Predicting Response to Immunotherapy and Prognosis in Patients with Gastric Cancer: DNA Damage Response Genes

Figure 6

Evaluation of risk model genes. (a) Correlation of risk model genes with risk scores. (b) Overall survival curves of high APOD expression group and low APOD expression group. (c) Mutation rates of three potentially high-risk genes. (d) Mutation loci of APOD. (e) Immunohistochemical results of APOD antigen in normal and tumor tissues.

(a)

(b)

(c)

(d)

(e)